Aliquots
-
June 2, 2016
Alzheimer’s risk gene in younger adults
A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age. -
May 13, 2016
New pain medicine from a fungus?
Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines. -
May 12, 2016
COX-2 blocker could help PTSD
COX-2 inhibitors – used clinically to reduce inflammation and pain – may find new applications for treating PTSD and other stress-related psychiatric disorders like major depression. -
May 3, 2016
Drug combos for glioblastoma
Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment. -
April 29, 2016
Improving natural killer cancer therapy
A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies. -
April 28, 2016
An Argonaute’s voyage to cancer
A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.” -
April 20, 2016
How strep grabs on to platelets
New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.